​

Equillium (EQ) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

EQ Stock Forecast

Equillium (EQ) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 203.03% increase from the last price of $1.98.

- $1 $2 $3 $4 $5 $6 High: $6 Avg: $6 Low: $6 Last Closed Price: $1.98

EQ Stock Rating

Equillium stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (81.82%), 2 Hold (18.18%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 2 9 Strong Sell Sell Hold Buy Strong Buy

EQ Price Target Upside V Benchmarks

TypeNameUpside
StockEquillium203.03%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$6.00$6.00$6.00
Last Closing Price$1.98$1.98$1.98
Upside/Downside203.03%203.03%203.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-31--4
Mar, 26-22--4
Feb, 26-12--3
Jan, 26-12--3
Dec, 25-12--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 13, 2026Raymond James$6.00$1.70252.94%203.03%
Mar 28, 2025Thomas SmithLeerink Partners$1.00$0.40150.00%-49.49%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 16, 2026B. RileyBuyinitialise
Apr 13, 2026Raymond JamesStrong Buyinitialise
Apr 02, 2024H.C. WainwrightBuyBuyhold
Dec 26, 2023CitigroupBuyBuyhold
Feb 08, 2023SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-10 $-4 $2 $8 $14 $20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.19$-0.38$-0.23$-0.39---
Avg Forecast$-1.67$-0.50$-0.55$-1.21$-1.20$-0.62$-0.13
High Forecast$-1.67$-0.42$16.90$-0.74$-1.20$-0.62$-0.13
Low Forecast$-1.67$-0.62$-9.27$-1.45$-1.20$-0.62$-0.13
Surprise %91.02%-24.00%-58.18%-67.77%---

Revenue Forecast

$0 $17M $34M $51M $68M $85M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.76M$36.08M$41.09M$130.00K---
Avg Forecast$18.00M$33.37M$31.85M$11.00M$15.58M$48.72M$84.11M
High Forecast$18.00M$36.99M$39.94M$11.00M$15.58M$48.72M$84.11M
Low Forecast$18.00M$27.46M$23.76M$11.00M$15.58M$48.72M$84.11M
Surprise %-12.45%8.14%29.03%-98.82%---

Net Income Forecast

$-350M $-160M $30M $220M $410M $600M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.43M$-13.34M$-8.07M$-22.40M---
Avg Forecast$-57.99M$-18.07M$-4.62M$-40.63M$-41.67M$-21.53M$-4.51M
High Forecast$-57.99M$-14.53M$586.70M$-25.81M$-41.67M$-21.53M$-4.51M
Low Forecast$-57.99M$-21.62M$-321.74M$-50.29M$-41.67M$-21.53M$-4.51M
Surprise %7.65%-26.21%74.80%-44.87%---

EQ Forecast FAQ

Is Equillium stock a buy?

Equillium stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Equillium is a favorable investment for most analysts.

What is Equillium's price target?

Equillium's price target, set by 11 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 203.03% change from the previous closing price of $1.98.

How does Equillium stock forecast compare to its benchmarks?

Equillium's stock forecast shows a 203.03% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Equillium over the past three months?

  • April 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Equillium’s EPS forecast?

Equillium's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.2, marking a 207.69% increase from the reported $-0.39 in 2025. Estimates for the following years are $-0.62 in 2027, and $-0.13 in 2028.

What is Equillium’s revenue forecast?

Equillium's average annual revenue forecast for its fiscal year ending in December 2026 is $15.58M, reflecting a 11881.54% increase from the reported $130K in 2025. The forecast for 2027 is $48.72M, and $84.11M for 2028.

What is Equillium’s net income forecast?

Equillium's net income forecast for the fiscal year ending in December 2026 stands at $-41.672M, representing an 86.05% increase from the reported $-22.398M in 2025. Projections indicate $-21.53M in 2027, and $-4.514M in 2028.